Improving and Increasing Diversity, Equity, and Inclusion in Digitized Clinical Trial Design and Implementation
Today’s clinical trials are neither diverse nor equitable nor inclusive. In fact, about 80 percent of participants are white, while only 45 percent are women.
This must change and the excuses end today.
Clinical trials that successfully engage, enroll, and retain underrepresented populations are possible. Use these resources to remove obstacles to assessing, identifying, and implementing digital tools in your clinical research. In doing so, you’ll help deliver new, safer drugs to the market for everyone.
The DiMe Diversity, Equity, and Inclusion in Digitized Clinical Trials project team represents the diversity of expertise and representation needed to advance clinical trials.
Advancing Diversity, Equity, and Inclusion in Action
Share this deck:
Tell us what you’re doing and how your work is advancing diversity, equity, and inclusion.
We want to hear from you! Tell us how you’re using any of our DEI tools across health care and research and we’ll publish a case study about your work.